SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-134206
Filing Date
2011-05-10
Accepted
2011-05-10 16:10:41
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 557224
2 LICENSE AGREEMENT dex1023.htm EX-10.23 365606
3 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6603
4 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7334
5 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4205
6 CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4212
  Complete submission text file 0001193125-11-134206.txt   946225
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 11828303
SIC: 2834 Pharmaceutical Preparations